光热治疗
光热效应
纳米颗粒
阿霉素
癌细胞
纳米技术
细胞毒性
癌症研究
活力测定
多重耐药
药物输送
生物物理学
体外
化学
药理学
癌症治疗
材料科学
纳米载体
癌症
化疗
生物化学
医学
抗生素
外科
内科学
生物
作者
Bing Xia,Qi Zhang,Jisen Shi,Jiachen Li,Zhenyu Chen,Bin Wang
标识
DOI:10.1016/j.colsurfb.2018.01.059
摘要
The development of nanoparticles-based drug delivery systems with a high therapeutic efficacy is necessary to treat multidrug-resistant (MDR) cancer cells. Herein, photothermal agents (IR820 dyes) and anticacner drugs (doxorubicin, DOX) were successively incorporated into amino-terminated porous silicon nanoparticles (NH2-PSiNPs) via electrostatic attractions, to prepare DOX/IR820/NH2-PSiNPs nanocomposites with a high loading amount of DOX (13.3%, w/w) and IR820 (18.6%, w/w), respectively. Meanwhile, DOX molecules were also directly loaded into NH2-PSiNPs to form DOX/NH2-PSiNPs nanocomposites (DOX, 18.7%, w/w). Compared with low release percentage (20.3%) of DOX molecules from DOX/NH2-PSiNPs in acidic environments under NIR laser irradiation, DOX/IR820/NH2-PSiNPs had dual pH/NIR light-triggered release and their release percentage could reach 88.1% under the same conditions. Furthermore, cellular interactions tests demonstrated that DOX/IR820/NH2-PSiNPs could delivery more DOX molecules into the nuclei of MDR cancer cells, with efficient intracellular release triggered by NIR light, in contrast to DOX/NH2-PSiNPs. Finally, DOX/IR820/NH2-PSiNPs exhibited an enhanced chemo-photothermal therapeutic efficacy (cell viability, 38.4%) of killing MDR cancer cells in vitro, compared with 85.4% of free DOX and 75.9% of DOX/NH2-PSiNPs. Therefore, based on PSiNPs-based nanocarriers conjugated with photothermal agents and anticancer drugs, NIR light-triggered drug delivery system with higher efficacy of combined chemo-photothermal therapy would have important potential on MDR cancer treatments in future.
科研通智能强力驱动
Strongly Powered by AbleSci AI